| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | betulinic acid | CTRPv2 | pan-cancer | AAC | -0.029 | 0.5 |
| mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | 0.029 | 0.5 |
| mRNA | necrostatin-1 | CTRPv2 | pan-cancer | AAC | 0.028 | 0.5 |
| mRNA | PF-562271 | GDSC1000 | pan-cancer | AAC | -0.025 | 0.5 |
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | -0.027 | 0.5 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | -0.039 | 0.5 |
| mRNA | paclitaxel | CTRPv2 | pan-cancer | AAC | 0.024 | 0.5 |
| mRNA | CHIR-99021 | GDSC1000 | pan-cancer | AAC | -0.023 | 0.5 |
| mRNA | Rapamycin | GDSC1000 | pan-cancer | AAC | 0.036 | 0.5 |
| mRNA | NSC-207895 | GDSC1000 | pan-cancer | AAC | 0.024 | 0.5 |